Cyclooxygenase-2 expression in human irradiated uveal melanomas

International Ophthalmology

Volumn 28, Issue 1, 2008, Pages 1-6

  Özdal, Pinar Ç ^a,b,c   Callejo, Sonia ^b   Caissie, Amanda L ^b   Edelstein, Chaim ^b   Bakalian, Silvin ^b   Vianna, Raul N G ^b   Burnier, Miguel N ^b  

^a Sehit Cevdet Özdemir Mah ^*  (Turkey)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c Ulucanlar Eye Research Hospital   (Turkey)

Author keywords

COX 2 expression; Enucleation; Irradiation; Tumorre growth; Uveal melanoma

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CLINICAL ARTICLE; CORRELATIONAL STUDY; DISEASE SEVERITY; ENUCLEATION; ENZYME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; RADIATION HAZARD; RADIATION INJURY; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CYCLOOXYGENASE 2; EYE ENUCLEATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; UVEAL NEOPLASMS;

EID: 39749088829     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9096-z     Document Type: Article

References (33)

1. Pyo H, Choy H, Amorino GP et al (2001) A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res 7:2998-3005
2. Kishi K, Petersen S, Petersen C et al (2000) Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res 60:1326-1331
3. Hinz B, Brune K (2002) Cyclooxygenase-2-10 years. J of Pharmacol Exp Ther 300:367-375
4. Milas L, Mason KA, Liao Z, Ang KK (2003) Chemoradiotherapy: Emerging treatment improvement strategies. Head & Neck 25:152-167
5. Eisengart CA, Mestre JR, Naama HA et al (2000) Prostaglandins regulate melanoma-induced cytokine production in macrophages. Cell Immunol 204:143-149
6. Xu XC (2002) COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs 13:127-137
7. Lin TD, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO (2002) Cyclooxygenase-2: A novel molecular target for the prevention and treatment of head and neck cancer. Head & Neck 24:792-798
8. Gaffney DK, Holden J, Zempolich K, Murphy KJ, Dicker AP, Dodson M (2001) Elevated COX-2 expression in cervical carcinoma. Reduced cause-specific survival and pelvic control. Am J Clin Oncol 24:443-446
9. Patti R, Gumired K, Reddanna P, Sutton LN, Phillips PC, Reddy CD (2002) Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: Effect of celecoxib and rofecoxib. Cancer Lett 180(1):13-21
10. Denkert C, Kobel M, Berger S et al (2001) Expression of cyclooxygenase-2 in human malignant melanoma. Cancer Res 61:303-308
11. Kuzbicki L, Sarnecka A, Chwirot BW (2006) Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression. Melanoma Res 16(1):29-36
12. Figueiredo A, Caissie AL, Callejo S, McLean IW, Gold P, Burnier Jr MN (2003) Cyclooxygenase-2 immune-expression in human uveal melanoma: A novel classification of mixed cell type tumors. Can J Ophthalmol 38:352-356
13. Leujeune FJ, Monnier Y, Rüegg C (2006) Complete and long-lasting regression of disseminated multiple skin melanoma metastases under treatment with cyclooxygenase-2 inhibitor. Melanoma Res 16(3):263-265
14. Milas L (2001) Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse. Semin Radiat Oncol 11(4):290-299
15. Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ (2000) Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res 6:2513-2520
16. Steinauer KK, Gibbs I, Ning S, French JN, Armstrong J, Knox SJ (2000) Radiation induces upregulation of cyclooxygenase -2 (COX-2) protein in PC-3 cells. Int J Radiat Oncol Biol Phys 48(2):325-328
17. Shields CL, Shields JA, Karlsson U, Menduke H, Brady LW (1990) Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings. Ophthalmol 97:1665-1670
18. Jampol LM, Moy CS, Murray TG et al (2002). The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 109:2197-2206
19. Diener-West M, Earle JD, Fine SL, et al, The Collaborative Ocular Melanoma Study (COMS) Group (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III. Initial mortality findings. COMS Report No. 18. Arch Ophthalmol 119:969-982
20. The Collaborative Ocular Melanoma Study (COMS) Group (1998) The COMS randomized trial of pre-enucleation radiation of large choroidal melanoma, I: Characteristics of patients enrolled and not enrolled. COMS Report No. 9. Am J Ophthalmol 125:767-778
21. Zimmerman LE, McLean IW, Foster WD (1978) Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? Br J Ophthalmol 62:420-425
22. McLean IW, Foster WD, Zimmerman LE (1980) Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci 19:760-770
23. Messmer E, Bornfeld N, Foerster M, Schilling H, Wessing A (1992) Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma. Graefe's Arch Clin Exp Ophthalmol 230:391-396
24. Pe'er J, Stefani FH, Seregard S et al (2001) Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: An EORTC ocular oncology group study. Br J Ophthalmol 85:1208-1212
25. Seregard S, Lundell G, Lax I, Trampe E, Kock E (1997) Tumor cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma. Acta Ophthalmol Scand 75:148-154
26. Pe'er J, Gnessin H, Shargal Y, Livni N (1994) PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups. Ophthalmology 101:56-62
27. Chiquet C, Grange JD, Ayzac L, Chauvel P, Patricot LM, Devouassoux-Shisheboran M (2000) Effects of proton beam irradiation on uveal melanoma: A comparative study of expression in irradiated versus non-irradiated melanomas. Br J Ophthalmol 84:98-102
28. Karlsson M, Boeryd B, Carstensen J, Franlund B, Gustafsson B, Kagedal B (1996) Correlation of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J Cancer 32A(2):357-362
29. Al-Jamal RT, Kivala T (2006) KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors. Curr Eye Res 31:57-67
30. Gaffney DK, Holden J, Davis M, Zempolich K, Murphy KJ, Dodson M (2001) Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 49:1213-1217
31. Kim HJ, Wu HG, Park IA, Ha SW (2003) High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 55(1):16-20
32. Kim YB, Kim GE, Cho NH et al (2002) Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer 95:531-539
33. Milas L, Kishi K, Hunter N, Mason K, Masferrer JL, Tofilon PJ (1999) Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. J Natl Cancer Inst 91:1501-1504